Register Now

Most of us care deeply about advocacy — but few truly understand the regulatory machinery that drives it.

Every year, federal agencies issue rules that directly affect how we practice, how we are paid, and how we care for our patients. Yet the structure, timing, and strategy behind these regulations often feel opaque and inaccessible.

The MSTS Advocacy Taskforce invites you to Advocacy Webinar #2:— a practical, big-picture overview designed specifically for musculoskeletal oncologists.

Why Attend?

This session will break down:

• Who actually makes the rules?
  Understanding HHS, CMS, and the federal regulatory structure.
• When do these rules come out — and why should we pay attention every year?
• How are we paid?
  IPPS, OPPS, ASC, and Physician Fee Schedules, RVUs, and the conversion factor.
• How do CPT codes get created or changed?
  A practical overview of CPT and the RUC process.
• What is CMMI? Where is value-based care heading?
  From early VBC models to TEAMS and beyond.
• How does AAOS and MSTS advocate on our behalf?
  Comment letters, direct meetings with CMS, and current priorities — including the efficiency adjustment and CY2026 Physician Fee Schedule updates.

What You’ll Gain

• A clear understanding of the regulatory process
• Insight into how payment policy directly affects musculoskeletal oncology
• Awareness of AAOS and MSTS current advocacy priorities
• Practical knowledge to become a more informed advocate

This is Regulatory 101 — built for orthopaedic oncologists who want to move beyond frustration and toward influence.

Join us and learn how the rules are written — and how our specialty can help shape them.

Featured Speakers

Jordan Heyman
Senior Director, Policy and Regulatory Affairs
Office of Government Relations, American Academy of Orthopaedic Surgeons

Adam Levin, MD
Associate Professor, Orthopaedic Oncology, Johns Hopkins University
Chair, MSTS Practice Management Committee

Moderators:
Susan McDowell, MD
Kelly Homlar, MD